Originality and innovation are watchwords for one of Europe’s newest cancer research funders
Top tips:
- Lymph&Co particularly appreciates interdisciplinary applications
- Lead applicants should have a strong publication record in lymphoma research or be able to demonstrate their expertise in the field in another way
- The charity welcomes fundamental, translational and clinical research bids
- Innovation is highly prized but where there is little precedent in the literature, preliminary data should be included
The charity Lymph&Co was formed in 2016 with much of the initial impetus coming from one of its co-founders, the Dutch royal family member Bernhard van Oranje. After recovering from lymphoma, van Oranje learnt that there was no dedicated Dutch fund for lymphoma research and set to work.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.